ChronosHub partners with American Chemical Society

Share this on social media:

Image: TATSIANAMA/Shutterstock.com

ChronosHub has announced a collaboration with the American Chemical Society (ACS). The ACS Journal Finder will make institutional and consortial open access agreements and funders’ open access policies more transparent for authors.

ChronosHub assisted ACS with a public journal finder tool that includes all of ACS’ more than 75 journals, now live at https://acs.chronoshub.io. Authors are presented with several options designed to help them identify the right journal for their manuscript submissions. They can select their funder and affiliated institution to see funder compliance requirements as well as potential eligibility for open access (OA) agreements negotiated by their institution or consortium. 

Either article publishing charges (APC) are displayed for the different compliant publishing routes, or an explicit text will underline that the APC is covered by an agreement. In addition, the journal finder offers filter options that allow authors to narrow down the presented options; they can filter the journals by subject, license, OA type, embargo period, and APC price.

Sybille Geisenheyner, director of open science strategy and licensing at ACS, said: ‘We are happy to partner with ChronosHub on this initiative, as it will be a valuable tool for our authors as they determine which journal is right for them. We are consistently undertaking new initiatives to ease the transition towards open access for our authors and look forward to implementing this tool in our researcher community.’

Christian Grubak, co-CEO at ChronosHub, added: ‘It’s a pleasure for us to be able to assist ACS on this journey to forge greater transparency for its authors. Fostering a simple and smooth author experience is key and by partnering with ACS, we’ll ensure that authors are provided with the right guidance throughout the process of selecting the right journal.’

Related news

Image: Billion Photos/Shutterstock.com

28 April 2022

Image: Sashkin/Shutterstock.com

05 April 2022

Image: kavalenkava/shutterstock.com

24 March 2022

Image: TATSIANAMA/Shutterstock.com

23 March 2022

Image: TATSIANAMA/Shutterstock.com

23 March 2022